PPARGC1A and Huntington disease: Crossing N171-82Q HD transgenic mice with inducible TRE-PGC-1α mice decreased aberrant aggregation and turnover of mutant HTT, mitigated striatal neurodegeneration, and improved mitochondrial dysfunction observed in HD mice (Tsunemi et al., 2012).